SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-22-010489
Filing Date
2022-05-23
Accepted
2022-05-23 16:06:36
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A meip-20210930.htm   iXBRL 10-Q/A 1992320
2 EX-31.1 meip-ex31_1.htm EX-31.1 18763
3 EX-31.2 meip-ex31_2.htm EX-31.2 18638
4 EX-32.1 meip-ex32_1.htm EX-32.1 13810
5 GRAPHIC img102216177_0.jpg GRAPHIC 70565
6 GRAPHIC img102216177_1.jpg GRAPHIC 21423
  Complete submission text file 0000950170-22-010489.txt   9309911

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20210930_def.xml EX-101.DEF 291454
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20210930_pre.xml EX-101.PRE 358160
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20210930_cal.xml EX-101.CAL 37424
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20210930.xsd EX-101.SCH 47740
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20210930_lab.xml EX-101.LAB 427090
58 EXTRACTED XBRL INSTANCE DOCUMENT meip-20210930_htm.xml XML 2121336
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-50484 | Film No.: 22951620
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences